… phase III study failed to demonstrate the superiority of gefitinib in terms of DFS and OS among
patients with completely resected stage II-III … The EVAN trial is the randomized phase II trial …

… This randomized, double-blind, placebo-controlled phase III study evaluated efficacy and
safety of pazopanib monotherapy in treatment-naive and cytokine-pretreated patients with …

The optimal adjuvant treatment for gastric cancer remains controversial. We compared the
efficacy of a docetaxel and platinum adjuvant chemotherapy regimen, in patients with high-…

… Based on these phase II studies, a phase III, multicenter, randomized trial of patients with …
for any of these approaches has yet to be demonstrated in randomized phase III trials. …

… documented throughout the multi-center prospective randomized phase III trial (OVAR-3)
of … In this study 798 patients with FIGO IIB–IV were first operated then randomized and …

… In this review, we evaluate the use of randomized phase II (RPh2) trials in studying multiple
treatment regimens. We are interested in identifying the types of RPh2 designs and how they …

… These results are in line with previously published randomized phase-111 studies in
adult patients, which also showed a reduction of infections under r-metHuG-CSF treatment. …

Purpose This randomized, multicenter, phase III trial evaluated the efficacy and safety of
trastuzumab and paclitaxel with or without carboplatin as first-line therapy for women with HER-2…

… the 37.5 mg CDD schedule was selected for further study. In this article, we report findings
from an open-label, phase III study comparing sunitinib versus sorafenib in advanced HCC. …

Background The treatment results of external beam radiotherapy for intermediate and high
risk prostate cancer patients are insufficient with five-year biochemical relapse rates of …